期刊文献+

胆红素浓度与冠心病和高血压病发生风险的相关性 被引量:5

Relationship between serum level of bilirubin and the risk of both coronary artery disease and hypertension
下载PDF
导出
摘要 目的探讨胆红素浓度与冠心病和高血压病发生风险的相关性,为心血管疾病的病因学研究以及治疗提供依据。方法以曾接受冠状动脉造影检查的患者为研究对象,从中选取冠心病212例、高血压198例以及冠心病合并高血压384例为病例组,冠状动脉造影阴性197例为阴性对照组。比较病例组和对照组以及病例组组间胆红素水平,统计学处理采用Wilcoxon秩和检验、卡方检验、Logistic回归分析。结果各病例组分别与对照组相比,总胆红素、直接胆红素、间接胆红素差异均具有统计学意义(P<0.001)。冠心病组和冠心病合并高血压组相比,总胆红素和间接胆红素差异具有统计学意义,P值分别为0.0299和0.0277。高血压组和冠心病合并高血压组相比,总胆红素、直接胆红素、间接胆红素差异均具有统计学意义,P值分别为0.0007、0.0006和0.0128。多因素Logistic回归分析表明:血清总胆红素浓度和冠心病、高血压发生负相关,OR值分别为0.832(P<0.001)、0.928(P=0.004)。这种相关性在不吸烟亚组和男性亚组更为显著。结论除了已知的危险因素外,血清胆红素低浓度也是冠心病、高血压的独立危险因素。 Objective To provide a target for the etiology research and treatment strategy of cardiovascular disease,, and to analyse the relationship between serum level of bilirubin and the risk of both coronary artery disease and hypertension. Methods Patients who underwent coronary angiography were enrolled. All these cases were divided into case groups and negative control group, case groups including coronary heart disease group (CHD), hypertension group, andgroup of subjects who are subjected to both coronary heart disease and hypertension, while coronary angiography negative group as the negative control. The serum level of bilirubinwere detected in each group, in order to find out if there is any statistically difference between the case groups and control group, or among the case groups. Differences were evaluated using SAS8.0 and SPSS17.0, and the data were assessed by Wilcoxonrs signed-rank test, Chi square test and Logistic regression analysis. Results A total of 991 cases were involved in this study. The levels of total bilirubin, direct bilirubin or indirect bilirubin, in three case groups were statistically significant (P^0.01) when compared to control group, respectively. Furthermore, the levels of total bilirubin and indirect bilirubin were statistically significant in CHD or Hypertension when compared to the group who are subjected to both CHD and Hypertension (P ~ 0. 05), respectively. Logistic regression analysis revealed the level of total bilirubin levels was negatively correlation with coronary artery disease (OR..0. 832, P%0. 001) or hypertension (OR:0. 928,P = 0. 004) , respectively. This correlation was more significant in non-smoking subgroup and male subgroup. Conclusion In addition to the known risk factors, low serum level of bilirubin was one of the new independent risk factors for cardiovascular disease and Hypertension.
出处 《肝脏》 2013年第6期365-368,共4页 Chinese Hepatology
基金 上海市公共卫生重点学科(12GWZX0903)
关键词 冠心病 高血压 胆红素 独立危险因素 Coronary heart disease Hypertension Bilirubin Independent risk factor
  • 相关文献

参考文献17

  • 1Wu TW, Fung KP, Wu J, et ai. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol, 1996, 51 : 859-862.
  • 2Neuzil J, Stoeker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem, 1994, 269: 16712- 16719.
  • 3Vitek L, Jirsa M, Brodanova M, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis, 2002, 160:449-456.
  • 4Pedro-Botet J, Covas MI, Martin S, et al. Decreased endogenous antioxidant enzymatic status in essential hypertension. J Hum Hypertens, 2000, 14:343-345.
  • 5Wang D, Strandgaard S, Iversen J, et al. Asymmetric dimethyl- arginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am J Physiol Regul Integr Comp Physiol, 2009, 296 .. R195-200.
  • 6Galley HF, Thornton J, Howdle PD, et al. Combination oral antioxidant supplementation reduces blood pressure. Clin Sci (Lond), 1997, 92:361-365.
  • 7Sedlak TW, Saleh M, Higginson DS, et al. Bilirubin and glutathione have complementary antioxidant and eytoprotective roles. Proe Natl Acad Sci USA, 2009, 106:5171-5176.
  • 8Vitek L, Schwertner HA. The heme catabolic pathway and its protective ef{eets on oxidative stress-mediated diseases. Adv Clin Chem, 2007, 43:1-57.
  • 9Mazzone GL, Rigato I, Ostrow JD, et al. Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules. Bioehem Biophys Res Commun, 2009, 386:338-344.
  • 10Tapan S, Dogru T, Tasci I, et al. Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis? Clin Biochem, 2009, 42:791-795.

同被引文献68

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部